The sale is small relative to market cap and appears to be a routine cashless option exercise. Monitor for any additional insider selling patterns in future Form 4 filings, but this single filing does not signal a change in company outlook.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $104.01entry
- T+1 · 6d ago +1.73%α +0.41% · $105.81
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bernard J Zovighian, an officer and director of Edwards Lifesciences, filed a Form 144 notice of intent to sell 46,200 shares of common stock with an approximate market value of $4.76 million. The shares are to be sold via a cashless exercise of employee stock options, with the sale to occur on or around November 9, 2026.
Key Facts
- Insider: Bernard J Zovighian (Officer and Director)
- Shares to be sold: 46,200 shares of common stock
- Approximate value: $4,759,559 (based on $103.02 per share implied by the filing)
- Sale method: Cashless exercise of employee stock options
- Filing date: November 9, 2026
- Broker: Charles Schwab & Co., Inc.
- Company market cap: $57.9 billion
Financial Impact
Sale of 46,200 shares valued at approximately $4.76 million, representing less than 0.01% of the company's $57.9 billion market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- Insider selling could be misinterpreted by the market, though the amount is immaterial.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-001150 |
| Document: 0001921094-26-001150-index.html | 0001921094-26-001150 |
| Document: 0001921094-26-001150.txt | 0001921094-26-001150 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Viewing Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers